Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 260

Cited In for PubMed (Select 19898493)

1.

MicroRNAs and Cardiac Regeneration.

Hodgkinson CP, Kang MH, Dal-Pra S, Mirotsou M, Dzau VJ.

Circ Res. 2015 May 8;116(10):1700-1711. Review.

PMID:
25953925
2.

Single-molecule analysis of myocyte differentiation reveals bimodal lineage commitment.

Gibson TM, Gersbach CA.

Integr Biol (Camb). 2015 Jun 8;7(6):663-71. doi: 10.1039/c5ib00057b. Epub 2015 May 8.

PMID:
25953198
3.

Differences in the gene expression profiles of slow- and fast-forming preinduced pluripotent stem cell colonies.

Kwon S, Park JS, Min B, Kang YK.

Stem Cells Int. 2015;2015:195928. doi: 10.1155/2015/195928. Epub 2015 Apr 7.

4.

Repressors of reprogramming.

Popowski M, Tucker H.

World J Stem Cells. 2015 Apr 26;7(3):541-6. doi: 10.4252/wjsc.v7.i3.541. Review.

5.

Forward engineering neuronal diversity using direct reprogramming.

Tsunemoto RK, Eade KT, Blanchard JW, Baldwin KK.

EMBO J. 2015 Jun 3;34(11):1445-1455. Epub 2015 Apr 23. Review.

PMID:
25908841
6.

Early reprogramming regulators identified by prospective isolation and mass cytometry.

Lujan E, Zunder ER, Ng YH, Goronzy IN, Nolan GP, Wernig M.

Nature. 2015 May 21;521(7552):352-6. doi: 10.1038/nature14274. Epub 2015 Apr 1.

PMID:
25830878
7.

A continuous molecular roadmap to iPSC reprogramming through progression analysis of single-cell mass cytometry.

Zunder ER, Lujan E, Goltsev Y, Wernig M, Nolan GP.

Cell Stem Cell. 2015 Mar 5;16(3):323-37. doi: 10.1016/j.stem.2015.01.015.

PMID:
25748935
8.

Regenerative Medicine for the Aging Brain.

Lopez-Leon M, Reggiani PC, Herenu CB, Goya RG.

Enliven J Stem Cell Res Regen Med. 2014;1(1):1-9.

9.

How the cell cycle impacts chromatin architecture and influences cell fate.

Ma Y, Kanakousaki K, Buttitta L.

Front Genet. 2015 Feb 3;6:19. doi: 10.3389/fgene.2015.00019. eCollection 2015.

10.

Molecular mechanisms of induced pluripotency.

Kulcenty K, Wróblewska J, Mazurek S, Liszewska E, Jaworski J.

Contemp Oncol (Pozn). 2015;19(1A):A22-9. doi: 10.5114/wo.2014.47134. Review.

11.

Fluorescent in situ sequencing (FISSEQ) of RNA for gene expression profiling in intact cells and tissues.

Lee JH, Daugharthy ER, Scheiman J, Kalhor R, Ferrante TC, Terry R, Turczyk BM, Yang JL, Lee HS, Aach J, Zhang K, Church GM.

Nat Protoc. 2015 Mar;10(3):442-58. doi: 10.1038/nprot.2014.191. Epub 2015 Feb 12.

PMID:
25675209
12.

cAMP and EPAC Signaling Functionally Replace OCT4 During Induced Pluripotent Stem Cell Reprogramming.

Fritz AL, Adil MM, Mao SR, Schaffer DV.

Mol Ther. 2015 May;23(5):952-63. doi: 10.1038/mt.2015.28. Epub 2015 Feb 10.

PMID:
25666918
13.

miR-290/371-Mbd2-Myc circuit regulates glycolytic metabolism to promote pluripotency.

Cao Y, Guo WT, Tian S, He X, Wang XW, Liu X, Gu KL, Ma X, Huang D, Hu L, Cai Y, Zhang H, Wang Y, Gao P.

EMBO J. 2015 Mar 4;34(5):609-23. doi: 10.15252/embj.201490441. Epub 2015 Jan 20.

PMID:
25603933
14.

Epigenetic predisposition to reprogramming fates in somatic cells.

Pour M, Pilzer I, Rosner R, Smith ZD, Meissner A, Nachman I.

EMBO Rep. 2015 Mar;16(3):370-8. doi: 10.15252/embr.201439264. Epub 2015 Jan 18.

PMID:
25600117
15.

Initiation and maintenance of pluripotency gene expression in the absence of cohesin.

Lavagnolli T, Gupta P, Hörmanseder E, Mira-Bontenbal H, Dharmalingam G, Carroll T, Gurdon JB, Fisher AG, Merkenschlager M.

Genes Dev. 2015 Jan 1;29(1):23-38. doi: 10.1101/gad.251835.114.

PMID:
25561493
16.

X chromosome reactivation dynamics reveal stages of reprogramming to pluripotency.

Pasque V, Tchieu J, Karnik R, Uyeda M, Sadhu Dimashkie A, Case D, Papp B, Bonora G, Patel S, Ho R, Schmidt R, McKee R, Sado T, Tada T, Meissner A, Plath K.

Cell. 2014 Dec 18;159(7):1681-97. doi: 10.1016/j.cell.2014.11.040.

PMID:
25525883
17.

Establishment of a primed pluripotent epiblast stem cell in FGF4-based conditions.

Joo JY, Choi HW, Kim MJ, Zaehres H, Tapia N, Stehling M, Jung KS, Do JT, Schöler HR.

Sci Rep. 2014 Dec 17;4:7477. doi: 10.1038/srep07477. Erratum in: Sci Rep. 2015;5:8180.

18.

Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain.

Kabadi AM, Thakore PI, Vockley CM, Ousterout DG, Gibson TM, Guilak F, Reddy TE, Gersbach CA.

ACS Synth Biol. 2015 Jun 19;4(6):689-99. doi: 10.1021/sb500322u. Epub 2014 Dec 31.

PMID:
25494287
19.

Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis.

Kareta MS, Gorges LL, Hafeez S, Benayoun BA, Marro S, Zmoos AF, Cecchini MJ, Spacek D, Batista LF, O'Brien M, Ng YH, Ang CE, Vaka D, Artandi SE, Dick FA, Brunet A, Sage J, Wernig M.

Cell Stem Cell. 2015 Jan 8;16(1):39-50. doi: 10.1016/j.stem.2014.10.019. Epub 2014 Nov 13.

20.

Cell signalling pathways underlying induced pluripotent stem cell reprogramming.

Hawkins K, Joy S, McKay T.

World J Stem Cells. 2014 Nov 26;6(5):620-8. doi: 10.4252/wjsc.v6.i5.620. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk